Laxmi Dental IPO GMP soars 33% on Day 3 – Here is why…

Laxmi Dental IPO, one of the mainboard public issues in January 2025, is catching the attention of investors with its Rs 698.06 crore offer. The IPO opened its bidding window on January 13 and will conclude today, January 15. On day 3 of bidding today, Laxmi Dental IPO has garnered significant attention in the grey market, with shares trading at a premium. However, it is important to note that this is not the actual listing price and may fluctuate depending on market sentiment.

Laxmi Dental IPO: GMP

On its final day of bidding, Laxmi Dental shares are making waves in the grey market. As per the latest update, the company’s shares are trading at a premium of Rs 142, indicating an estimated listing price of Rs 570 per share, which is 33.18% higher than the issue’s upper price band of Rs 428 per share.

Laxmi Dental IPO: Subscription number

So far, on the third day of bidding, the issue has been subscribed 26.84 times in total, with the retail portion subscribed 43.43 times, the QIB category subscribed 0.97 times, and the NII portion subscribed 67.54 times.

Also Read: Capital Infra Trust InVIT IPO: Check GMP, allotment status, and key details ahead of listing

“The company ranks among the top two dental laboratories in India by revenue and is the leading exporter of dental products. We believe that going forward company’s growth factor could be driven by trends such as the changing regulatory requirements in the medical devices sector helps transition from unorganized to organized players, increasing awareness and demand for dental aesthetics, and the growing preference for metalfree dental products. Hence considering all parameters, we recommend the issue can be consider as “SUBSCRIBE for LONG TERM”,” said Anand Rathi research in an IPO note.

Laxmi Dental IPO: Key highlights

The Laxmi Dental IPO consists of a fresh issue of 0.32 crore shares worth Rs 138 crore and an offer for sale of 1.31 crore shares amounting to Rs 560.06 crore, with a price band of Rs 407 to Rs 428 per share.

Laxmi Dental IPO: Allotment and listing

The allotment of shares after its bidding completion is expected to be finalised by January 16, with the tentative listing date set for January 20, on both the BSE and NSE.

 » Read More

Related Articles

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain

Range bound session: Nifty ends above 23,600, Sensex holds 78,000 led by Adani Ports, Infosys

The stock markets faced a downturn on Thursday, with major indices closing in the red. The BSE Sensex dropped by 213.12 points or 0.27%, ending the day at 78,058.16, while the NSE Nifty 50 saw a decline of 70.15 points, down by 0.3%, and closed at 23,626.15. The Nifty Bank index also ended the day

IT stocks stable as Cognizant raises annual and quarterly revenue guidance

Shares of Indian IT companies are in the spotlight today after the Nasdaq-listed IT services major Cognizant Technology Solutions, reported its Q4 results that exceeded Wall Street expectations. The Nifty IT Index as well as individual tech counters like Infosys, Wipro, Tech Mahindra and HCL Tech are all in the green even as the markets